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A B S T R A C T
The Republic of Angola is a priority country for onchocerciasis and lymphatic ﬁlariasis (LF)
elimination, however, the co-distribution of the ﬁlarial parasite Loa loa (loiasis) is a signiﬁcant
impediment, due to the risk of severe adverse events (SAEs) associated with ivermectin used in
mass drug administration (MDA) campaigns. Angola has a high risk loiasis zone identiﬁed in
Bengo Province where alternative interventions may need to be implemented; however, the
presence and geographical overlap of the three ﬁlarial infections/diseases are not well deﬁned.
Therefore, this study conducted a rapid integrated ﬁlarial mapping survey based on readily
identiﬁable clinical conditions of each disease in this risk zone to help determine prevalence and
co-distribution patterns in a timely manner with limited resources. In total, 2007 individuals
from 29 communities in ﬁve provincial municipalities were surveyed. Community prevalence
estimates were determined by the rapid assessment procedure for loiasis (RAPLOA) and rapid
epidemiological mapping of onchocerciasis (REMO) together with two questions on LF clinical
manifestations (presence of lymphoedema, hydrocoele). Overall low levels of endemicity, with
diﬀerent overlapping distributions were found. Loiasis was found in 18 communities with a
prevalence of 2.0% (31/1571), which contrasted to previous results deﬁning the area as a high
risk zone. Onchocerciasis prevalence was 5.3% (49/922) in eight communities, and LF
prevalence was 0.4% for lymphoedema (8/2007) and 2.6% for hydrocoeles (20/761 males) in
seven and 12 communities respectively. The clinical mapping survey method helped to highlight
that all three ﬁlarial infections are present in this zone of Bengo Province. However, the
signiﬁcant diﬀerence in loiasis prevalence found between the past and this current survey
suggests that further studies including serological and parasitological conﬁrmation are required.
This will help determine levels of infection and risk, understand the associations between clinical,
serological and parasitological prevalence patterns, and better determine the most appropriate
treatment strategies to reach onchocerciasis and LF elimination targets in the loiasis co-endemic
areas. Our results also suggest that the utility of the earlier RAPLOA derived maps, based on
surveys undertaken over a decade ago, are likely to be invalid given the extent of population
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movement and environmental change, particularly deforestation, and that ﬁne scale micro-
mapping is required to more precisely delineate the interventions required deﬁned by these
complex co-endemicities.
1. Introduction
The Republic of Angola is a priority country for onchocerciasis and lymphatic ﬁlariasis (LF) elimination in sub-Saharan Africa
(World Health Organization, 2015a, 2015b; World Health Organization, 2016a, 2016b). These two human ﬁlarial infections are key
neglected tropical diseases (NTDs) listed by the World Health Organization (WHO), and considered to be major public health
problems, causing widespread disability and consequent poverty (World Health Organization, 2012a; World Health Organization,
2013a, 2013b, 2016c). Global elimination eﬀorts primarily aim to interrupt transmission with preventive chemotherapy through
mass drug administration (MDA) using ivermectin, albendazole and diethylcarbamazine (DEC) in diﬀerent regimen combinations and
to alleviate suﬀering through morbidity management and disability prevention (MMDP). While many countries in Africa have made
steady progress in scaling up their national programmes, several countries, including Angola, are behind the targets if the WHO
Roadmap is to be accomplished (Bockarie et al., 2013; Molyneux et al., 2016; World Health Organization, 2012a). In Central and
West Africa, perhaps the most signiﬁcant impediment for programmes is the co-distribution of the ﬁlarial parasite L. loa, due to the
risk of severe adverse events (SAEs) including encephalopathy and death, which have been associated with ivermectin when given to
individuals with high L. loa microﬁlariae (mf) loads in the blood (> 30,000 mf/ml) (Boussinesq, 2006; Gardon et al., 1997; Kelly-
Hope et al., 2014; Twum-Danso, 2003).
The distribution of L. loa is restricted to the African equatorial rain forest and is transmitted by the tabanid ﬂies Chrysops spp.
(Kelly-Hope et al., 2017a). Typical clinical infections include Calabar swelling, pruritus and sub-conjuctival migration of the adult L.
loa worm, which is an indication of- and referred to- as loiasis or Tropical Eye Worm (Boussinesq, 2006; World Health Organization,
2016c); however more recently a study has found excess mortality associated with high infection rates (Chesnais et al., 2016). The
problem of SAEs associated with ivermectin was initially reported during MDA in onchocerciasis control programmes in Cameroon
and later in the Democratic Republic of Congo (DRC), as a result of which, the African Programme for Onchocerciasis Control (APOC)
(Cupp et al., 2011; Dadzie, 1997) developed the rapid assessment survey method for loiasis (RAPLOA) based on eye worm history
(Addiss et al., 2003; Takougang et al., 2002; Wanji et al., 2005, 2012). The extensive RAPLOA surveys undertaken have helped
develop loiasis prevalence maps and predict areas at highest risk of SAEs (Takougang et al., 2002; Zouré et al., 2011). In parallel,
advice to national onchocerciasis elimination programmes about how the risk of SAEs should be mitigated, and if they occur, be
managed is based on the Guidelines established by the Mectizan Donation Programme Expert Committee (the Mectizan Expert
Committee, MEC) (Addiss et al., 2003; Alleman et al., 2006; Colatrella, 2008; Ogoussan and Hopkins, 2011), now with technical
expertise from the new Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) (Hopkins, 2016; World
Health Organization, 2015a, 2015b).
Angola has a L. loa high risk area in Bengo Province in the northwest region of the country with high prevalence estimates
(> 40%) and associated risk of SAEs (Zouré et al., 2011). These risks were deﬁned by RAPLOA surveys conducted in 2003, 2004 and
2008, and support historical studies on ﬁlariasis, which also found widespread onchocerciasis caused by Onchocerca volvulus and
transmitted by the Simulium spp. vectors, but little evidence of the LF parasite Wuchereria bancrofti (Casaca, 1966a, 1966b; Hawking,
1974). The current prevalence of LF in this area is not known, but is expected to be low based on the historical data and recent
modelled map estimates developed by Cano et al. (2014), though these were based on a few data points. Baseline mapping is required
to determine the way forward. However, it will be important to take into account the ongoing activities of the onchocerciasis
programme that currently operates in some areas of Bengo Province.
Angola has seven high risk onchocerciasis areas being targeted with the annual community-directed treatment with ivermectin
(CDTI) strategy, one of which overlaps with part of the loiasis high risk zone (World Health Organization, 2016a, 2016b, 2016c,
2016d; Zouré et al., 2014). The CDTI areas were identiﬁed through the Rapid Epidemiological Mapping for Onchocerciasis (REMO)
(Noma et al., 2002), which is based on community prevalence of skin nodules ≥20% in adults, as part of APOC's strategy to target
and control blinding onchocerciasis (Ngoumou et al., 1994; Zouré et al., 2014). However, the recent change in strategy to expand and
eliminate onchocerciasis, by treating low transmission areas (nodule prevalence< 20%) poses several challenges, which are being
considered by ESPEN (Hopkins, 2015, 2016; Molyneux et al., 2014a; World Health Organization, 2015a, 2015b). These challenges
relate to the fact that hypo-endemic areas are geographically vast and diﬃcult for health services to access, and not currently well-
deﬁned; ivermectin cannot be used in L. loa areas as the risk of SAEs outweighs the beneﬁts to the community, and there is no
recommended alternative safe strategy that is readily scalable in the L. loa co-endemic areas despite the development of the new 'test
and not treat' (TNT) strategy (D'Ambrosio et al., 2015; Kamgno et al., 2016; Pion et al., 2016a).
The situation for implementing an alternative strategy for LF elimination in L. loa co-endemic areas is more straightforward, but
not without challenges. While the WHO/Global Programme to Eliminate LF (GPELF), recommends the alternative strategy of twice a
year albendazole together with the use of long-lasting/insecticide treated bed nets (LLIN/ITNs) (Kelly-Hope et al., 2013; World
Health Organization, 2012b); only one or two countries out of the 10 L. loa co-endemic countries have started to implement this
alternative strategy. The reasons for such delays are multi-faceted, but mainly related to political instability, poor infrastructure and
diﬃcult access to communities, (Molyneux et al., 2014a). A new practical approach for scaling up the alternative strategy may help
countries to develop action plans, however they will need considerable funding and support at a national level (Kelly-Hope et al.,
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2017b). The other main challenge relates to measuring endemicity, which has largely been deﬁned in Africa through mapping
community prevalence of ﬁlarial antigen detected with the rapid diagnostic immuno-chromatographic test (ICT) card (BinaxNOW
Filariasis), and now more recently the Filariasis Test Strip (FTS) (Weil et al., 2013; Weil and Ramzy, 2007). However, recent evidence
indicates a cross-reactivity problem with the ICT card in high risk L. loa areas resulting in false positives and potentially an
overestimation of LF prevalence (Bakajika et al., 2014; Pion et al., 2016b; Wanji et al., 2015, 2016).
For the Angolan onchocerciasis and LF national programmes to implement MDA using ivermectin as a constituent drug, it is
critical to understand the extent to which the three ﬁlarial infections overlap geographically. This will ensure that safe treatment
strategies are implemented, and monitored for impact and potential SAEs. The large-scale RAPLOA and REMO surveys provide
essential baseline information; however they were completed at diﬀerent times, and on diﬀerent and relatively large geographical
scales. Micro-mapping and overlap-mapping are new approaches developed to delineate risk, deﬁne co-endemicity and target
interventions which may be more useful in this loiasis high risk zone, which comprises both hyper- and hypo-onchocerciasis, and an
unknown LF prevalence (Kelly-Hope et al., 2011, 2014, 2015; Okorie et al., 2013). Given that the programmes in Angola are behind
targets for the achievement of elimination and have minimal funding support, the method to initially assess co-endemicity needs to be
simple, rapid and relatively cost eﬀective. Further for onchocerciasis, the use of skin snips and/or the new OV16 RDT (rapid
diagnostic test) are currently not feasible or aﬀordable at a large scale in this low-resource setting (Renneker et al., 2016). For LF, the
problem of the cross-reactivity in L. loa endemic areas with the ICT card highlights that an alternative method is required, and in the
absence of any new or alternative diagnostic tool, the presence of the main clinical symptoms of lymphoedema and hydrocoele may
help to identify if LF is a public health problem.
This aim of this study was to support the national LF Programme and conduct an integrated ﬁlarial mapping survey to help
determine the presence and co-distributions of onchocerciasis and LF in an area previously identiﬁed as one of high risk of L. loa
SAEs. The study builds on the RAPLOA and REMO survey methods by adding LF clinical symptoms, and implements it on a ﬁne
geographical scale within this high risk zone, which also helps to construct a rapid integrated ﬁlarial ‘RAPLOA-REMO-LF’ clinical
survey using a new micro-mapping approach.
Fig. 1. Study areas and location of study sites in relation to modelled ﬁlarial distributions.A. Angola and study area.B. Study sites and loiasis.C. Study sites and
onchocerciasis.D. Study sites and LF.
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2. Methods
2.1. Bengo Province
The study was conducted in rural and semi-rural villages across six municipalities in the north-western province of Bengo, Angola
where the loiasis endemicity was considered to be high as determined by a previous RAPLOA study, the onchocerciasis endemicity
was moderate to low as determined by REMO, and the LF endemicity low as determined by recent published modelled maps,
including historical records, which were imported into ArcGIS 10 (ESRI, Redlands CA) and digitized to created new maps with
comparative prevalence/endemicity levels for the purpose of this study (Fig. 1A–D) (Cano et al., 2014; Zouré et al., 2011, 2014).
Bengo Province borders Luanda (south), Zaire (north), Uige (northeast), and Cuanza Norte (east) provinces, and has an area of 31,371
sq.km and a population of 351,579 with the majority of people living in rural areas with basic housing, and limited access to
electricity, clean water or sanitation (Governo da República de Angola, 2014). Bengo Province has a tropical climate, with an average
temperature of 25 °C (range 20°–29 °C) and a rainy season from October to April with peaks in November/December and March/
April. It has large areas of rain forest as part of Kissama National Park and Kibinda Forest Reserve, as well as forest-savanna mosaic,
savannah and woodland vegetation. Several large rivers run through the province including the Dande River, which ﬂows rapidly
from the higher eastern region to the western lowlands where it ﬂows slowly through the capital, Caxito, into the Atlantic ocean.
2.2. Study sites
The study was primarily focussed in the CISA area (Centro de Investigacao em Saude de Angola/Health Research Centre of
Angola) of Dande Municipality, which comprises the three communes of Caxito, Mabubas and Ucua. The CISA includes the Dande
Health Demographic Surveillance System (HDSS-Dande), which operates an ongoing population monitoring system across 69 geo-
referenced neighbourhoods (here referred to as communities) comprising approximately 16,000 households, and a population of
approximately 60,000 inhabitants in an area of 4700 sq.km (Costa et al., 2012). The population density is approximately 13
inhabitants per km2, and has both urban and rural characteristics, with 16 communities in the main town of Caxito. The landscape is
primariy savanna with a forest gallery around the river banks and higher areas. The Dande, Lifune and Ucaua rivers run through the
area and have permanent water ﬂow, with many lakes surrounding lower parts of the Dande. Fig. 2 shows photos of the landscape,
including rivers, vegetation and typical houses. In addition to the CISA area, additional communities from the adjacent municipalities
of Ambriz, Nambuangongo, Dembos, Bula Atumba and Pango Aluquem were sampled in order to provide preliminary insights into
the geographical extent and prevalence of ﬁlarial infections.
2.3. Mapping strategy and ﬁeld logistics
To determine the prevalence and co-distribution of the three ﬁlarial diseases at a ﬁne geographical scale across the CISA study
area, a rapid integrated micro-mapping activity assessing the evidence of key clinical conditions was conducted in January and
February 2014. One community was randomly selected from within a 15 km grid which was created in the geographical information
system (GIS) software (ArcInfo 10, ESRI, Redland CA) to demarcate a 5 to 15 km distance between each, to ensure that prevalence
was measured at regular spatial intervals across the entire study area and to incorporate a range of environmental characteristics.
In the adjacent ﬁve municipalities, only one or two communities were selected to provide insights into the endemicity in the
surrounding CISA areas. Communities were included if they reported> 100 adult (> 15 years) inhabitants during the last DSS
Fig. 2. Photos of landscape and typical housing in the CISA study area.
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survey. In each community, all adults present at the time were invited to participate, and the ﬁrst 100 individuals accepting the
invitation were included in the survey. The mapping survey was implemented by the local CISA research team based in Caxito. In
total ﬁve research assistants were trained in the detection of loiasis, onchocerciasis and LF clinical conditions using a short
questionnaire and physical examination, in accordance with the rapid mapping assessment methods for loiais and onchocerciasis
(described below). In each community, 100 individuals were targeted to be surveyed over a 2 to 3 week period, with the
questionnaires administered in Portuguese.
2.4. Filarial clinical indicators
2.4.1. Loa loa
To determine the prevalence of L. loa the rapid assessment procedure for loiaisis (RAPLOA) diagnostic survey method was used
(Takougang et al., 2002; Zouré et al., 2011). The method was developed and validated by the WHO, reviewed by the Technical
Consultative Committee of APOC and approved for loiasis mapping in Africa. RAPLOA is based on an individual's history of eye
worm, with information obtained from a simple short non-invasive survey comprising three questions relating to past experience of
eye worm, conﬁrmed by a photograph of the L. loa adult worm in the white part of the eye, and with the duration of the most recent
episode being between 1 and 7 days;
1. Have you ever experienced or noticed worms move along the white of your eye? (yes/no)
2. Have you ever had the condition in this picture? (yes/no)
3. How long (in days) did the worm stay before disappearing? (between 1 and 7; yes/no)
Loiasis was conﬁrmed in an individual when the answers to the three questions were all positive ‘yes’. This is considered to be the
restricted deﬁnition of eye worm or loiasis, and has been found to correlate with high L. loa mf rates and risk of SAEs (Addiss et al.,
2003). An unrestricted deﬁnition of loiasis is considered to be a positive response to the ﬁrst question only. In each community,
individuals aged> 15 years and whom had resided in the area for at least 5 years were selected for assessment.
2.4.2. Onchocerciasis
To determine the prevalence of onchocerciasis, the basis of the REMO method was used (Ngoumou et al., 1994; Noma et al.,
2002). The standard REMO method was developed for APOC to delineate zones of endemicity, identify CDTI-priority areas and
estimate the number of people to be treated. It samples a proportion of villages to determine the prevalence in the local area by
feeling for sub-cutaneous worm nodules (caused by Onchocerca volvulus adult worms living under the skin) in 50 adult males, who are
aged≥20 years and have lived in the community for at least 10 years. If≥20% of adults have nodules, the local area is considered to
be a CDTI-priority area, and where nodule prevalence is< 20% then clinic-based treatment is applied. In this current study the
REMO method was used. However, because the area was hypo-endemic both males and females were included.
2.4.3. Lymphatic ﬁlariasis
To determine the presence of LF, an assessment of the main clinical conditions including limb lymphoedema (tissue swelling or
thickening), and hydrocoele (scrotal swelling) was conducted. In Africa, the clinical conditions are caused by Wuchereria bancrofti
adult worms lodging in the lymphatic system and disrupting the immune system and lymph carriage. Currently, there are no standard
rapid mapping guidelines to detect LF clinical cases; however, new approaches using local health workers and simple mHealth tools
have started to be used in the ﬁeld (Stanton et al., 2016). For this study, the presence of lymphoedema and/or hydrocoele in
individuals aged> 15 years was recorded and veriﬁed by a local medical oﬃcer. No severity of the condition was recorded.
2.5. Data analysis and mapping
All survey data were entered into Microsoft Excel 2010 by the CISA team, and IBM SPSS statistical version 21 software was used
for analysis. Prevalence distributions by sex (male, female), and age class (15–19, 20–29, 30–29, 40–49, 50–59, ≥60) were
summarised and statistical diﬀerences examined using the chi-square test (p-value signiﬁcant< 0.05). The GPS locations of the
communities and households within the CISA area were available from the DSS in Dande. The ﬁlarial prevalence in each CISA
community was mapped using ArcGIS 10 (ESRI, Redland CA), and communities found to have more than ﬁve cases and multiple
ﬁlarial diseases were further mapped by household to better understand the co-distribution at a micro-level.
2.6. Ethics, consent and patient referrals
The survey was approved by the Ethical Committees from the Ministry of Health of Angola (Conselho de ética do Ministério da
Saúde de Angola) and the Liverpool School of Tropical Medicine Research. Written informed consent was obtained from each
respondent and was orally explained if respondents were illiterate. A parent or guardian provided written informed consent on behalf
of child participants. For those who refused to participate, no further questions were asked and no information was recorded. For
those individuals who consented, their name, sex, age and years of residence in the community were recorded before proceeding with
the questions about ﬁlarial clinical conditions. For individuals found to be positive for clinical conditions, information on risk factors
and prevention were provided, and they were referred to the local health services, which had previously been informed of the
M. Brito et al. Parasite Epidemiology and Control 2 (2017) 71–84
75
survey's activities. As part of the DSS in Dande, an established communication system is already in place between the CISA team and
all community clinics, therefore good support and follow-up for the patients could be provided.
3. Results
3.1. Field work
The study was conducted in January and February 2014. In total, 29 community study sites were sampled across the six
municipalities with the majority from the CISA area in Dande Municipality (Table 1). All study sites were within endemic areas of
loiasis, onchocerciasis and LF as deﬁned by the modelled maps with a range of prevalence distributions as shown in the digitized
maps in Fig. 1A–D. For loiasis, all sites were in pre-deﬁned high risk ‘hyper-endemic’ areas (> 40%), for onchocerciasis the majority
of sites were in pre-deﬁned low risk ‘hypo-endemic’ areas (< 20%) with approximately one third in CDTI priority areas (≥20%), and
for LF, all sites were in very low (< 5%) or low (5–20%) ‘hypo-endemic’ areas as deﬁned by the modelled mf map.
Approximately half of the sites (n = 13; 48.1%) had lower than the expected number of adults meeting the inclusion criteria,
which is likely due to population movements associated with long-term civil conﬂict, seasonal (agricultural) employment, charcoal
activity and rural-to-urban immigration trends, which is now common in this area after the war. This limited the analysis as it was not
possible to include the necessary sample size of 100 individuals or assess the prevalence in those individuals, who are most often men,
as they were not present, apparently working outside the village.
In total, 2007 individuals were surveyed, with numbers ranging from nine to 149 in each community study site. There were 761
males (37.9%) and 1246 females (62.1%), with average age of 40 years, ranging from 15 to 94 years based on 1558 individuals
reporting their age. Fig. 3 presents the sampling and analysis framework for each disease with details on the numbers, prevalence
rates by age, sex and community study site described below and outlined in Tables 2–6.
3.2. RAPLOA survey
For loiasis, 1571 individuals were included in the community analysis based on the RAPLOA inclusion criteria. In total, 346
individuals (22.0%) stated that had experienced a worm moving in their eye; of those 55 individuals (16% of 346; 3.5% of 1571)
conﬁrmed the worm with the picture shown by the interviewer, with 31 individuals (56% of 55; 2% of 1571) conﬁrming the most
recent episode being between 1 and 7 days (Table 2, Fig. 3). There were no signiﬁcant diﬀerences between males and females in the
unrestricted and restricted eye worm deﬁnitions (Table 5). Of the 29 communities surveyed, a total of 18 communities were found to
have loiasis positive individuals based on the restricted deﬁnition.
Overall, prevalence ranged from 0% to 10%, and the distribution in the CISA areas only is shown in Fig. 4A, which highlights that
positive communities are located throughout the area with no obvious geographical pattern or clustering. When examining
prevalence by age and sex (based on 1558 individuals who provided information), overall no signiﬁcant diﬀerences between males
and females or by age class were found (Table 4). Community-level age and sex analysis was not possible due to the low numbers,
with most communities reporting one or two loiasis cases, and only Tabi (Ambriz Municipality) and Muxaluando (Nambuangongo
Municipality) reporting three to ﬁve positive cases including both sexes and a range of age classes.
3.3. REMO survey
For onchocerciasis, there were 922 individuals from eight communities who were included in the analysis based on the REMO
inclusion criteria, with 49 individuals (5.3%) found to have palpable nodules (Table 3; Fig. 3). Of the 29 communities surveyed,
initially 18 communities found positive individuals, however only eight communities met the required minimum numbers of 50 male
adults. For the purpose of this study in a hypo-endemic area, all data were included in the analysis and mapped. Overall, the
prevalence ranged from 4.8% to 7.6% in the eight REMO communities, and from 2.9% and 42.9% in the other communities with
fewer individuals surveyed. The distribution of all communities in the CISA area is shown in Fig. 4B, which highlights that the
positive communities are located throughout the study area with no speciﬁc geographical pattern. When examining prevalence by
age, overall there was an increasing prevalence by age, which was found to be signiﬁcant overall, and in the female sub-group
Table 1
Summary of study sites, population and individual samples.
Municipality Populationa N of sampled villages N examined N males N females Average age (years)
Dande 217,929 23 1.380 495 885 41.00
Ambriz 21,806 2 191 51 140 39.18
Pango-Aluquem 6,571 1 99 54 45 31.00
Dembos-Quimbaxe 28,202 1 117 56 61 26.00
Bula Atumba 16,047 1 116 60 56 36.39
Nambuangongo 61,024 1 104 45 59 34.67
Total 351,579 29 2.007 761 1246 40.09
a Total population recorded during the National Census 2014.
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(Table 6). Community-level age and sex analysis was not possible due to the low numbers of only three to seven positive cases found
in each community.
3.4. Lymphatic ﬁlariasis clinical signs
For LF, all 2007 individuals were eligible for inclusion in this study. In total, eight individuals (0.4%) were found to have leg
lymphoedema and 20 men were found to have hydrocoele (2.6%) (Table 4; Fig. 3). Of the 29 communities surveyed, a total of seven
communities reported lymphoedema cases, 12 communities reported hydrocoele cases and three communities reported both clinical
conditions, however, diﬀerent individuals were aﬀected. For lymphoedema, no signiﬁcant diﬀerences by age and sex were found;
however for hydrocoele, there was an increasing prevalence by age class with signiﬁcant diﬀerences found (P-value < 0.001). The
highest hydrocoele prevalence rates were reported among men aged over 50 years, which ranged from 3.4% to 8.5% (Table 6). The
distribution of LF clinical cases for the CISA area are shown in Fig 4C and D, and highlight that there is no speciﬁc geographical
pattern for either condition and a very low prevalence of lymphoedema in the area.
3.5. Micro-mapping co-distributions
Overall, there was no distinct geographical pattern of the presence or absence of the diﬀerent ﬁlarial diseases in each of the CISA
study communities. Four communities were found to co-endemic for all three ﬁlarial diseases, and four communities had none. The
presence of loiasis cases alone was found in two villages, onchocerciasis cases alone in one community, and LF cases alone in two
communities. The presence of loiasis and onchocerciasis cases was found in four communities, and loiasis and LF cases in two
communities, while the presence of onchocerciasis and LF cases was found in four communities.
The communities of Boa Esperança 2, Honga Hungo, Kilometro 29, Mussenga, Sassa Povoação were found to have ≥5 ﬁlarial
cases and were located across the study area (Fig. 5A). The results from the micro-mapping are presented in Fig. 5B–F, and highlight
the ‘within-community’ distribution of each ﬁlarial disease. Only one individual from one household in Boa Esperança 2 community
was found to have clinical conditions related to two diseases (loiasis and onchocerciasis) while all other communities reported the
presence of cases from diﬀerent households, indicating the absence of co-infection.
Total sample
2007
RAPLOA REMO LF Proxy
(2007)
Lymphodema
8 / 2007
Nodule positive
85 / 2007
< 20 y old
< 10 years residente 
(1085)
Q1 and Q2 yes
55 / 2007
Q1, Q2 and Q3 yes
31 / 2007
Q3 no
24
< 5 yresidente
(436)
female
1246
Hydrocoele
20 / 761
Loiasis positive
31 / 1571
Onchocerciasis 
positive
49 / 922
Fig. 3. Sampling and analysis framework.
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Table 2
Summary of loiasis distribution measured by RAPLOA methods.
Municipality Village N examined N included RAPLOAa Positives loiasis % Positive loiasis
Dande 1380 1010 18 1.8
200 144 1 0.7
Açucareira Sede 99 68 1 1.5
Sassa Povoação 101 76 0 0.0
670 501 12 2.4
Boa Esperança 2 100 89 2 2.2
Bunba 41 26 2 7.7
Honga Hungo 46 33 1 3.0
Icau Centro 24 22 1 4.5
Jungo 99 65 2 3.1
Kilometro 29 27 20 2 10.0
Mabubas 125 95 1 1.1
Mazaza 25 18 0 0.0
Muceque Teba 34 18 0 0.0
Muculo 52 44 1 2.3
Quilengues 32 30 0 0.0
Santa Ambuleia 65 41 0 0.0
62 41 2 4.8
Caprédio 9 4 0 0.0
Lifune Napasso Kicabo 53 37 2 5.4
448 324 3 0.9
Catuta 36 31 0 0.0
Cherú 48 37 1 2.7
Coragem 100 67 1 1.5
Kacamba 25 11 0 0.0
Mussenga 98 71 0 0.0
Três Casas 92 74 1 1.4
Vida e Sacriﬁcio 49 33 0 0.0
Ambriz 191 185 4 2.2
Capulo 42 42 1 2.4
Tabi 149 143 3 2.1
Pango-Aluquem
Cazuangono 99 87 2 2.3
Dembos-Quimbaxe
Coqueiros 117 87 0 0
Bula Atumba
Ibundo 116 106 2 1.9
Nambuangongo
Muxaluando 104 96 5 5.2
Total Bengo – 2007 1571 31 2.0%
a Persons older than 15 years old and that have been resident in the village for at least 5 years.
Fig. 4. Filarial prevalence distributions in CISA communities.A. Loiasis.B. Onchocerciasis.C. LF Hydrocoele.D. LF Lymphoedema.
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4. Discussion
This is the ﬁrst survey in Angola to determine the presence of three ﬁlarial infections using rapid ﬁeld methods based on key
disease speciﬁc clinical conditions. The approach builds on the well-established RAPLOA and REMO survey methods, which have
been used extensively across Central and West Africa to deﬁne prevalence distributions and direct treatment strategies (Noma et al.,
2002; Takougang et al., 2002; Zouré et al., 2014). To-date, only one integrated RAPLOA-REMO survey in neighbouring DRC has been
reported, which found signiﬁcant diﬀerences in co-endemicity across the country (Tekle et al., 2011). Bordering Angola, the Bas
Congo region in DRC had reported SAEs (World Health Organization, 2004a, 2004b), and the availability of both loiasis and
onchocerciasis data, enabled simple maps and models to be developed to highlight the speciﬁc high risk areas (Kelly-Hope et al.,
2015, 2014). This is particularly important for Angola, as the current study in Bengo Province was conducted in a previously deﬁned
high risk area (Zouré et al., 2011), where all three diseases were found to be present.
The rapid integrated ﬁlarial ‘RAPLOA-REMO-LF’ clinical survey method used here in Angola also included a new micro-mapping
approach to determine prevalence distributions at a ﬁne geographical scale. Study communities were mapped on a scale of ~5-15 km
apart, which helped to highlight the wide variability in prevalence of all three infections in the relatively small CISA area (Costa et al.,
2012). However, due to some small community sample sizes, and a highly mobile population with some potentially ‘at risk
individuals’ absent from the study, accurate estimates of risk were compromised. This fact highlights how risk and population
dynamics can change over time, and that there is a need for up-to-date information and assessments before treatment strategies are
implemented. Notwithstanding, these limitations the overall prevalence was low (deﬁned as meso-to-hypo endemic), with no obvious
spatial patterns found, the communities with a higher risk of one or more diseases were readily identiﬁable. This has provided
important preliminary information to the national programmes as a ‘ﬁrst step’ in understanding the local ﬁlarial epidemiology, and
will help to investigate community risk in more detail as a ‘second step’ by assessing serological and parasitological prevalence rates,
Table 3
Summary of onchocerciasis nodules distribution measured by REMO methods.
Municipality commune Village N examined N included REMOa Positives nodules % Positive nodules
Dande 1380 486 26 5.3
Caxito 200 97 6 6.2
Açucareira Sede 99 34 1 2.9
Sassa Povoação 101 63 5 7.9
670 261 15 5.7
Boa Esperança 2 100 66 5 7.6
Bunba 41 18 0 0.0
Honga Hungo 46 7 3 42.9
Icau Centro 24 16 1 6.3
Jungo 99 23 1 4.3
Kilometro 29 27 10 1 10.0
Mabubas 125 55 3 5.5
Mazaza 25 7 0 0.0
Muceque Teba 34 8 0 0.0
Muculo 52 18 0 0.0
Quilengues 32 7 0 0.0
Santa Ambuleia 65 26 1 3.8
62 24 0 0.0
Caprédio 9 1 0 0.0
Lifune Napasso Kicabo 53 23 0 0.0
448 104 5 4.8
Catuta 36 21 2 9.5
Cherú 48 25 0 0.0
Coragem 100 19 0 0.0
Kacamba 25 7 1 14.3
Mussenga 98 8 1 12.5
Três Casas 92 17 1 5.9
Vida e Sacriﬁcio 49 7 0 0.0
Ambriz 191 163 7 4.3
Capulo 42 33 0 0.0
Tabi 149 130 7 5.4
Pango-Aluquem
Cazuangono 99 63 3 4.8
Dembos- quimbaxe
Coqueiros 117 50 3 6.0
Bula Atumba
Ibundo 116 86 5 5.8
Nambuangongo
Muxaluando 104 74 5 6.8
Total Bengo – 2007 922 49 5.3%
a Persons older than 20 years old and that have been resident in the village for at least 10 years.
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and other potential risk factors including the main vectors of loiasis (Chrysops spp.) and onchocerciasis (Simulium spp.). It will also
help to determine if alternative intervention strategies are required (Kelly-Hope et al., 2015, 2017a, 2017b).
For loiasis, a signiﬁcant diﬀerence was found between the current survey data with the RAPLOA modelled maps from 2010 (Zouré
et al., 2011). The reason for this signiﬁcant diﬀerence is unclear, but may be related to the timing and spatial resolution of data
collected as previous surveys were only conducted in a few villages between 2003 and 2008 (Zouré et al., 2011). It may also be
related to levels of deforestation, tree cover change, recent seasonal migration patterns as many people were not available for the
survey, and/or urbanisation changes in the area (Costa et al., 2012; Governo da República de Angola, 2014; Hansen et al., 2013;
World Resources Institute, 2017). Further investigations are needed to better determine L. loa prevalence, as it may be
underestimated. If the L. loa risk is found to be meso- endemic, then the risk of SAEs is also likely to be higher. However, the
proportion of individuals with high L. loa mf loads (≥30,000 ml) in such meso-endemic areas is unknown as only a few studies have
been conducted, and primarily focussed on the relationship between RAPLOA and mf rates in high transmission areas (Addiss et al.,
Table 4
Summary of clinical lymphatic ﬁlariasis distribution measured by the presence of lymphoedema and hydrocoele.
Municipality Village N examined Positives
lymphoedema
% Positive
lymphoedema
N male Positives
hydrocoele
% Positive
hydrocoele
Dande
Caxito
Açucareira Sede 99 0 0.0 24 0 0.0
Sassa Povoação 101 1 1.0 32 0 0.0
Boa Esperança 2 100 0 0.0 30 0 0.0
Bunba 41 0 0.0 17 0 0.0
Honga Hungo 46 0 0.0 15 1 6.7
Icau Centro 24 0 0.0 8 1 12.5
Jungo 99 0 0.0 33 0 0.0
Kilometro 29 27 0 0.0 10 2 20.0
Mabubas 125 0 0.0 37 0 0.0
Mazaza 25 1 4.0 15 0 0.0
Muceque Teba 34 0 0.0 21 2 9.5
Muculo 52 0 0.0 24 1 4.2
Quilengues 32 0 0.0 16 0 0.0
Santa Ambuleia 65 2 3.1 32 0 0.0
Caprédio 9 0 0.0 4 0 0.0
Lifune Napasso
Kicabo
53 0 0.0 14 1 7.1
Catuta 36 0 0.0 7 0 0.0
Cherú 48 1 2.1 16 1 6.3
Coragem 100 0 0.0 29 0 0.0
Kacamba 25 0 0.0 14 2 14.3
Mussenga 98 0 0.0 43 4 9.3
Três Casas 92 0 0.0 34 1 2.9
Vida e Sacriﬁcio 49 0 0.0 20 0 0.0
Total
Ambriz
Capulo 42 0 0.0 5 0 0.0
Tabi 149 1 0.7 46 2 4.3
Total 191 1 0.5 51 2 3.9
Pango-Aluquem
Cazuangono 99 0 0.8 0 0 0.0
Dembos- quimbaxe
Coqueiros 117 1 0.9 56 0 0.0
Bula Atumba
Ibundo 116 0 0.0 60 0 0.0
Nambuangongo
Muxaluando 104 1 1.0 45 2 4.4
Total – 2007 8 0.4 761 20 2.6
Table 5
Comparison of loiasis prevalence based on restricted and unrestricted RAPLOA deﬁnitions.
N examined N included in
RAPLOAa
N Positives yes
to 1 question
% Positives yes
to 1 question
N Positives yes to
2 questions
% Positives yes to
2 questions
N Positives yes to
3 questions
% Positives yes to
3 questions
Total 2007 1571 346 22.0 55 3.5 31 2.0
Male 761 592 117 19.7 17 2.9 15 2.0
Female 1246 979 229 23.4 38 3.9 25 2.0
a Persons older than 15 years old and that have been resident in the village for at least 5 years.
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2003; Boussinesq et al., 2001; Schlüter et al., 2016; Takougang et al., 2002; Wanji et al., 2012). Therefore, new investigations in these
meso-‘intermediate/transition’ zones are required, potentially using alternative measurement tools such as the CellScope Loa through
the test and not treat (TNT) strategy (D'Ambrosio et al., 2015), which may be better able to address these complex risk areas, and help
develop ‘intermediate transmission’ models to better predict risk of SAEs.
For onchocerciasis and LF, there was more correlation between the current survey results and modelled levels of endemicity.
However, it is important to note that higher onchocerciasis prevalence was found in drug naïve communities outside the deﬁned
Table 6
Prevalence of loiasis, onchocerciasis and lymphatic ﬁlariasis by sex and age class.
Prevalence
Loiasis Onchocerciasis Lymphatic ﬁlariasis
Lymphoedema Hydrocoele
Age class N % N % N % N %
Total 15 to 19 167 1.8 – – 254 0.8 – –
20 to 29 312 1.3 214 1.4 439 0.2 – –
30 to 39 275 2.9 199 3.5 356 0.6 – –
40 to 49 242 2.1 149 5.4 292 0.0 – –
50 to 59 269 1.5 164 7.9 318 0.3 – –
> 60 293 2.4 196 9.2 332 0.6 – –
Chi-square ns p < 0.001 Ns – –
Male 15 to 19 80 2.5 – – 116 0.0 116 0.0
20 to 29 110 0.0 86 1.2 157 0.6 157 0.6
30 to 39 92 3.3 65 6.2 118 0.8 118 0.8
40 to 49 86 2.3 51 3.9 108 0.0 108 1.9
50 to 59 95 1.1 51 7.8 116 0.0 116 3.4
> 60 125 1.6 87 6.9 142 0.7 142 8.5
Chi-square ns Ns Ns p < 0.001
Female 15 to 19 87 1.1 – – 138 1.4 – –
20 to 29 202 2.0 128 1.6 282 0.0 – –
30 to 39 183 2.7 134 2.2 238 0.4 – –
40 to 49 156 1.9 98 6.1 184 0.0 – –
50 to 59 174 1.7 113 8.0 202 0.5 – –
> 60 168 3.0 109 11.0 190 0.5 – –
Chi-square ns p < 0.001 Ns – –
Fig. 5. Micro-mapping ﬁlarial cases in high risk communities.
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CDTI area, and coincided with communities with a high prevalence of loiasis. A better understanding of the risks and beneﬁts of
extending the current CDTI boundaries or whether alternative strategies including doxycycline (Molyneux et al., 2003), and/or vector
control for both Simulium spp. and Chrysops spp. are required (Kelly-Hope et al., 2017a). An extensive review of Chrysops spp. suggests
that various forms of vector control (tiny targets as used in tsetse control) or new repellent approaches to deter biting of day biting
vectors [emanators] may reduce risk and thus L. loamf loads, which could be a novel intervention in low onchocerciasis transmission
areas (Kelly-Hope et al., 2015, 2017a). Such hypo-endemic onchocerciasis areas are now priority for ESPEN (World Health
Organization, 2015a, 2015b), who could provide further strategic, operational and technical support for the implementation and
systematic monitoring of safe and eﬀective strategies.
For LF, the few clinical cases veriﬁed by medical oﬃcers helped to conﬁrm that they were not inguinal hernias. There may be
more and/or missed hydrocoele cases in the community given the mobility of the population and social sensitivities of exposing legs
and genitalia. However, it is likely that the well-monitored DSS operating in this region would have identiﬁed the magnitude of the
problem already. While the hydrocele rates in low endemic areas may not be a reliable predictor of prevalence compared with highly
endemic communities (Eigege et al., 2003; Gyapong et al., 1998), the data indicate that transmission is low, which is in accordance
with historical data (Casaca, 1966a, 1966b). A random sample of night bloods to detect microﬁlaraemia may have helped to conﬁrm
the low LF prevalence, and could be included in the more detailed ‘second step’ serological assessments in the future. Nonetheless,
this initial clinical survey, suggests that LF transmission may be readily interrupted with the WHO recommended alternative strategy
of albendazole twice yearly plus vector control (Kelly-Hope et al., 2017b; World Health Organization, 2012b).
Further for LF, collaborative links with the national malaria control programme will be essential to help increase bed net
coverage, which is very low with only around one third of households owning an ITN (Cosep Consultoria Consaúde and ICF
International, 2011). Morbidity management and disability prevention may be readily addressed through home-based lymphoedema
care, and surgery for the few men identiﬁed with hydrocoele (World Health Organization, 2013a, 2013b). This epidemiological
pattern of low LF prevalence in L. loa endemic area has been found elsewhere (Bakajika et al., 2014; Bregani et al., 2007; Tekle et al.,
2011), and supports the idea that elimination may be more easily achieved in these co-endemic areas than previously thought. This
LF-loiasis pattern also supports the idea of competitive exclusion of ﬁlarial parasites in Africa (Molyneux et al., 2014b), and the lack
of co-infection at individual and household level found in this study supports this, and similar to another integrated mapping study
conducted in Nigeria (Brant, 2014).
The ﬁlarial endemicity found in Bengo Province is potentially complex. Therefore, a better understanding of the extent and
intensity of serological and parasitological co-infections is essential, and how risk and populations may have changed since the
original loiasis mapping is required for the scale-up of safe and eﬀective treatment strategies (Molyneux et al., 2014a). It is feasible
that the rapid integrated clinical survey method presented here could be conducted across a larger geographical region in selected
‘data naïve’ co-endemic areas as an initial risk mapping model. This will highlight the range of co-endemic patterns in the diﬀerent
regions of the country, and provide a broader perspective of the potential resources, speciﬁc investigations and technical expertise
that may be needed. This is important as the Angolan LF and onchocerciasis elimination programmes will face several challenges in
implementing and monitoring the impact of several intervention strategies across the country (Molyneux et al., 2014a). It will require
signiﬁcant collaboration, and human and ﬁnancial support from international partners and stakeholders over the next 5 years in
order to accelerate activities to meet national targets and global goals (World Health Organization, 2012a; World Health
Organization, 2015a, 2015b).
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